RCRecallCheck

Official recall atom

Two lots of Teva-Pregabalin 150 mg capsules recalled due to cross-contamination with the drug sertraline

Official fact2026-08-15Government of Canada recalls and safety alertsAtlas binding present

Unmatched ≠ safe. A missing record is not a safety clearance. Coverage is incomplete and dated. This site is not medical advice and does not publish drug labels, openFDA, Prop 65 or NIH DSLD records.

Official action

Source. Government of Canada recalls and safety alerts

Official identifier. ca-recall-82496

Date. 2026-08-15

Jurisdiction. Canada

Hazard (official). Contamination

Action / remedy (official). If you experience a serious allergic reaction (anaphylaxis), stop taking the affected product and seek immediate medical help by calling 9-1-1. Otherwise, do not stop taking your pregabalin medication without first speaking with your healthcare professional or pharmacist, as stopping suddenly may cause withdrawal symptoms including insomnia, nausea, headache, anxiety, excessive sweating, diarrhea, and convulsions.Return the product to the pharmacy where it was purchased as soon as possible for a replacement or alternative supply, and for proper disposal. If you are unsure whether your product is recalled, check with your pharmacy.Seek medical attention if you have used this product and think you are experiencing side effects.Contact Teva Canada Customer Care by calling toll-free at 1-800-268-4129 or by email at customer.service@tevacanada.com, if you have questions about this recall.Report any health product-related side effects or complaints to Health Canada.

Official record

Licence: Open Government Licence – Canada

Related paths